This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
Apolipoprotein E (Apo-E)P02649The platelet microparticle proteome.
J Proteome Res. 2005 Sep-Oct;4(5):1516-21.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 2007 Jun;9(6):654-9. Epub 2007 May 7.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomes with immune modulatory features are present in human breast milk.
J Immunol. 2007 Aug 1;179(3):1969-78.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649The proteome of red cell membranes and vesicles during storage in blood bank conditions.
Transfusion. 2008 May;48(5):827-35.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649The proteome of red cell membranes and vesicles during storage in blood bank conditions.
Transfusion. 2008 May;48(5):827-35.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649The proteome of red cell membranes and vesicles during storage in blood bank conditions.
Transfusion. 2008 May;48(5):827-35.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649The proteome of red cell membranes and vesicles during storage in blood bank conditions.
Transfusion. 2008 May;48(5):827-35.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Isolation and identification of potential urinary microparticle biomarkers of bladder cancer.
J Proteome Res. 2008 May;7(5):2088-96. doi: 10.1021/pr700775x. Epub 2008 Mar 29.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated protein.
Biochem Biophys Res Commun. 2009 Jan 16;378(3):433-8. doi: 10.1016/j.bbrc.2008.11.050. Epub 2008 Nov 24.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Large-scale proteomics and phosphoproteomics of urinary exosomes.
J Am Soc Nephrol. 2009 Feb;20(2):363-79. doi: 10.1681/ASN.2008040406. Epub 2008 Dec 3.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)Q03247Anchorage-independent growth of breast carcinoma cells is mediated by serum exosomes.
Exp Cell Res. 2009 Jul 1;315(11):1875-88. doi: 10.1016/j.yexcr.2009.03.010. Epub 2009 Mar 24.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02650Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes.
J Proteome Res. 2008 Dec;7(12):5157-66.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures.
Blood. 2009 Jul 16;114(3):723-32. doi: 10.1182/blood-2009-02-205930. Epub 2009 Apr 15.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes.
J Cell Physiol. 2009 Oct;221(1):221-31. doi: 10.1002/jcp.21847.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Differential stimulation of monocytic cells results in distinct populations of microparticles.
J Thromb Haemost. 2009 Jun;7(6):1019-28. doi: 10.1111/j.1538-7836.2009.03434.x.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Differential stimulation of monocytic cells results in distinct populations of microparticles.
J Thromb Haemost. 2009 Jun;7(6):1019-28. doi: 10.1111/j.1538-7836.2009.03434.x.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques.
Circ Cardiovasc Genet. 2009 Aug;2(4):379-88. doi: 10.1161/CIRCGENETICS.108.842849. Epub 2009 May 14.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomics of microparticles after deep venous thrombosis.
Thromb Res. 2010 Jun;125(6):e269-74. doi: 10.1016/j.thromres.2010.01.019. Epub 2010 Feb 13.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.
Immunol Cell Biol. 2010 Nov-Dec;88(8):851-6. doi: 10.1038/icb.2010.64. Epub 2010 May 11.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: Trophic support for axons?
Proteomics Clin Appl. 2007 Nov;1(11):1446-61. doi: 10.1002/prca.200700522. Epub 2007 Oct 16.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Microfiltration isolation of human urinary exosomes for characterization by MS.
Proteomics Clin Appl. 2010 Jan;4(1):84-96. doi: 10.1002/prca.200800093. Epub 2009 Nov 11.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
Proteomics. 2011 Jun;11(12):2459-75. doi: 10.1002/pmic.201000443. Epub 2011 May 18.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Fragment)E7ERP7Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
Proteomics. 2011 Jun;11(12):2459-75. doi: 10.1002/pmic.201000443. Epub 2011 May 18.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Fragment)Q8TCZ8Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
Proteomics. 2011 Jun;11(12):2459-75. doi: 10.1002/pmic.201000443. Epub 2011 May 18.
ENOG4111MYC347 / 0 / 347
mRNA for apolipoprotein E (apo E) (Fragment)Q6LBZ1Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
Proteomics. 2011 Jun;11(12):2459-75. doi: 10.1002/pmic.201000443. Epub 2011 May 18.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
Proteomics. 2011 Jun;11(12):2459-75. doi: 10.1002/pmic.201000443. Epub 2011 May 18.
ENOG4111MYC347 / 0 / 347
mRNA for apolipoprotein E (apo E) (Fragment)Q6LBZ1Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
Proteomics. 2011 Jun;11(12):2459-75. doi: 10.1002/pmic.201000443. Epub 2011 May 18.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic analysis of microvesicles derived from human colorectal cancer ascites.
Proteomics. 2011 Jul;11(13):2745-51. doi: 10.1002/pmic.201100022. Epub 2011 Jun 1.
ENOG4111MYC347 / 0 / 347
Apolipoprotein EQ6PAH0Proteomics of microparticles after experimental pulmonary embolism.
Thromb Res. 2012 Jul;130(1):122-8. doi: 10.1016/j.thromres.2011.09.016. Epub 2011 Oct 19.
ENOG4111MYC347 / 0 / 347
Apolipoprotein EQ6PAH0Proteomics of microparticles after experimental pulmonary embolism.
Thromb Res. 2012 Jul;130(1):122-8. doi: 10.1016/j.thromres.2011.09.016. Epub 2011 Oct 19.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections.
PLoS One. 2011;6(10):e26588. doi: 10.1371/journal.pone.0026588. Epub 2011 Oct 26.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)Q03247Bovine milk exosome proteome.
J Proteomics. 2012 Feb 16;75(5):1486-92. doi: 10.1016/j.jprot.2011.11.017. Epub 2011 Nov 23.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649The protein interaction network of extracellular vesicles derived from human colorectal cancer cells.
J Proteome Res. 2012 Feb 3;11(2):1144-51. doi: 10.1021/pr200842h. Epub 2012 Jan 9.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Quantitative proteome profiling of normal human circulating microparticles.
J Proteome Res. 2012 Apr 6;11(4):2154-63. doi: 10.1021/pr200901p. Epub 2012 Mar 1.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.
Nat Med. 2012 Jun;18(6):883-91. doi: 10.1038/nm.2753.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages.
J Immunol. 2012 Jul 15;189(2):744-54. doi: 10.4049/jimmunol.1102244. Epub 2012 Jun 18.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment.
PLoS One. 2012;7(7):e37279. doi: 10.1371/journal.pone.0037279. Epub 2012 Jul 12.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment.
PLoS One. 2012;7(7):e37279. doi: 10.1371/journal.pone.0037279. Epub 2012 Jul 12.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome.
Int J Proteomics. 2012;2012:971907. doi: 10.1155/2012/971907. Epub 2012 Jul 18.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts.
J Proteomics. 2012 Dec 21;77:344-56. doi: 10.1016/j.jprot.2012.09.008. Epub 2012 Sep 20.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts.
J Proteomics. 2012 Dec 21;77:344-56. doi: 10.1016/j.jprot.2012.09.008. Epub 2012 Sep 20.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy.
PLoS One. 2012;7(10):e46822. doi: 10.1371/journal.pone.0046822. Epub 2012 Oct 8.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02650Urinary exosomes and diabetic nephropathy: a proteomic approach.
Mol Biosyst. 2013 Jun;9(6):1139-46. doi: 10.1039/c2mb25396h.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02650Urinary exosomes and diabetic nephropathy: a proteomic approach.
Mol Biosyst. 2013 Jun;9(6):1139-46. doi: 10.1039/c2mb25396h.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.
J Proteomics. 2013 Apr 26;82:193-229. doi: 10.1016/j.jprot.2013.01.012. Epub 2013 Jan 30.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)Q03247Bovine milk proteome: quantitative changes in normal milk exosomes, milk fat globule membranes and whey proteomes resulting from Staphylococcus aureus mastitis.
J Proteomics. 2013 Apr 26;82:141-54. doi: 10.1016/j.jprot.2013.02.013. Epub 2013 Feb 28.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
Proteomics. 2013 May;13(10-11):1672-86. doi: 10.1002/pmic.201200562.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
Proteomics. 2013 May;13(10-11):1672-86. doi: 10.1002/pmic.201200562.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions.
Proteomics. 2013 Jul;13(14):2125-34. doi: 10.1002/pmic.201200323.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties.
Mol Cell Proteomics. 2013 Aug;12(8):2205-19. doi: 10.1074/mcp.M113.028589. Epub 2013 May 8.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system.
Cell Host Microbe. 2013 May 15;13(5):521-34. doi: 10.1016/j.chom.2013.04.009.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Modulation of B-cell exosome proteins by gamma herpesvirus infection.
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):E2925-33. doi: 10.1073/pnas.1303906110. Epub 2013 Jul 1.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Characterization of human thymic exosomes.
PLoS One. 2013 Jul 2;8(7):e67554. doi: 10.1371/journal.pone.0067554. Print 2013.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis.
PLoS One. 2013 Jul 8;8(7):e68451. doi: 10.1371/journal.pone.0068451. Print 2013.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649LRRK2 secretion in exosomes is regulated by 14-3-3.
Hum Mol Genet. 2013 Dec 15;22(24):4988-5000. doi: 10.1093/hmg/ddt346. Epub 2013 Jul 25.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18396. eCollection 2012.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression.
PLoS One. 2013 Sep 19;8(9):e75054. doi: 10.1371/journal.pone.0075054. eCollection 2013.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma.
Proteomics. 2013 Nov;13(22):3354-64. doi: 10.1002/pmic.201300282. Epub 2013 Oct 18.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Exosomes from myeloid-derived suppressor cells carry biologically active proteins.
J Proteome Res. 2014 Feb 7;13(2):836-43. doi: 10.1021/pr400879c. Epub 2013 Dec 13.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG4111MYC347 / 0 / 347
cDNA FLJ26517 fis, clone KDN07769Q6ZP45Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG4111MYC347 / 0 / 347
mRNA for apolipoprotein E (apo E) (Fragment)Q6LBZ1Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomal proteins in the aqueous humor as novel biomarkers in patients with neovascular age-related macular degeneration.
J Proteome Res. 2014 Feb 7;13(2):581-95. doi: 10.1021/pr400751k. Epub 2014 Jan 16.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Plasma biomarker discovery in preeclampsia using a novel differential isolation technology for circulating extracellular vesicles.
Am J Obstet Gynecol. 2014 Mar 18. pii: S0002-9378(14)00248-8. doi: 10.1016/j.ajog.2014.03.038.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Plasma biomarker discovery in preeclampsia using a novel differential isolation technology for circulating extracellular vesicles.
Am J Obstet Gynecol. 2014 Mar 18. pii: S0002-9378(14)00248-8. doi: 10.1016/j.ajog.2014.03.038.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Plasma biomarker discovery in preeclampsia using a novel differential isolation technology for circulating extracellular vesicles.
Am J Obstet Gynecol. 2014 Mar 18. pii: S0002-9378(14)00248-8. doi: 10.1016/j.ajog.2014.03.038.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Quantitative proteomics of extracellular vesicles released from human monocyte-derived macrophages upon beta-glucan stimulation.
J Proteome Res. 2014 May 2;13(5):2468-77. doi: 10.1021/pr4012552. Epub 2014 Apr 16.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Human urinary exosomes as innate immune effectors.
J Am Soc Nephrol. 2014 Sep;25(9):2017-27. doi: 10.1681/ASN.2013101066. Epub 2014 Apr 3.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02650Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicity.
J Proteomics. 2014 May 30;103:227-40. doi: 10.1016/j.jprot.2014.04.008. Epub 2014 Apr 18.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02650Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicity.
J Proteomics. 2014 May 30;103:227-40. doi: 10.1016/j.jprot.2014.04.008. Epub 2014 Apr 18.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Discovery of prognostic biomarker candidates of lacunar infarction by quantitative proteomics of microvesicles enriched plasma.
PLoS One. 2014 Apr 21;9(4):e94663. doi: 10.1371/journal.pone.0094663. eCollection 2014.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Discovery of prognostic biomarker candidates of lacunar infarction by quantitative proteomics of microvesicles enriched plasma.
PLoS One. 2014 Apr 21;9(4):e94663. doi: 10.1371/journal.pone.0094663. eCollection 2014.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Discovery of prognostic biomarker candidates of lacunar infarction by quantitative proteomics of microvesicles enriched plasma.
PLoS One. 2014 Apr 21;9(4):e94663. doi: 10.1371/journal.pone.0094663. eCollection 2014.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Discovery of prognostic biomarker candidates of lacunar infarction by quantitative proteomics of microvesicles enriched plasma.
PLoS One. 2014 Apr 21;9(4):e94663. doi: 10.1371/journal.pone.0094663. eCollection 2014.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
J Proteomics. 2014 Jun 25;106:191-204. doi: 10.1016/j.jprot.2014.04.028. Epub 2014 Apr 24.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P18649Characterization of the canine urinary proteome.
Vet Clin Pathol. 2014 Jun;43(2):193-205. doi: 10.1111/vcp.12147. Epub 2014 Apr 28.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Human T-lymphotropic Virus Type 1-infected Cells Secrete Exosomes That Contain Tax Protein.
J Biol Chem. 2014 Aug 8;289(32):22284-305. doi: 10.1074/jbc.M114.549659. Epub 2014 Jun 17.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Extravillous trophoblast cells-derived exosomes promote vascular smooth muscle cell migration.
Front Pharmacol. 2014 Aug 11;5:175. doi: 10.3389/fphar.2014.00175. eCollection 2014.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Extravillous trophoblast cells-derived exosomes promote vascular smooth muscle cell migration.
Front Pharmacol. 2014 Aug 11;5:175. doi: 10.3389/fphar.2014.00175. eCollection 2014.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes.
Sci Rep. 2014 Aug 29;4:6232. doi: 10.1038/srep06232.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS.
J Proteome Res. 2014 Oct 8.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS.
J Proteome Res. 2014 Oct 8.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS.
J Proteome Res. 2014 Oct 8.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS.
J Proteome Res. 2014 Oct 8.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets.
Transfusion. 2014 Oct 21. doi: 10.1111/trf.12874.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets.
Transfusion. 2014 Oct 21. doi: 10.1111/trf.12874.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
ENOG4111MYC347 / 0 / 347
[1] [2] [3] [4]